Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X:
“All roads ESMO
ESMO25 lead to Hamburg Auditorium, Berlin, CityCube A the Tumor Agnostic session kicks off in 15 mins! Grab your espresso and stroll over. You don’t want to miss this. Cancer Research Tumor Agnostic POWERHOUSE PERSPECTIVES in 90 mins:
- Clinician’s view – Vivek Subbiah
- Statistician’s view – Stefan Michiels (Villejuif)
- Pathologist’s view – Fernando Lopez-Rios (Madrid)
- Regulator’s view – Francesco Pignatti (Amsterdam)
Plus 30 min interactive Q&A!”
You Can Also Read:
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
ESMO 2025 Day 3 Highlights Not to Miss
